Cardiol Therapeutics (CRDL) Assets Average (2021 - 2026)
Cardiol Therapeutics' (CRDL) quarterly Assets Average came in at $19.9 million in Q1 2026, down 1.75% YoY from $20.3 million in Q1 2025, and up 51.22% on a QoQ basis from $13.2 million in Q4 2025.
Cardiol Therapeutics (CRDL) Assets Average (2021 - 2026) Analysis & Trends
Cardiol Therapeutics (CRDL) has 6 years of Assets Average data on file, last reported at $19.9 million in Q1 2026.
- Quarterly Assets Average fell 1.75% year-over-year to $19.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.9 million (down 1.75% YoY) and the FY2025 annual result came in at $19.9 million, down 20.13% from the prior year.
- Assets Average improved to $19.9 million in Q1 2026, from $13.2 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $66.2 million in Q1 2022 to a low of $11.9 million in Q3 2025.
- A 5-year average of $31.5 million and a median of $25.0 million in 2024 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2022 — Assets Average surged 100.82% — and 2024, when it plunged 52.28%.
- Tracing CRDL's Assets Average over 5 years: stood at $49.1 million in 2022, then plunged by 39.79% to $29.5 million in 2023, then plunged by 39.65% to $17.8 million in 2024, then fell by 26.1% to $13.2 million in 2025, then soared by 51.22% to $19.9 million in 2026.
- The last three Assets Average figures came in at $19.9 million (Q1 2026), $13.2 million (Q4 2025), and $11.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 5.97 Bn |
| 10 | Cardiol Therapeutics | 211.60 Mn | 192.74 Mn | - | 22.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.92 Mn |
| Dec 31, 2025 | 13.17 Mn |
| Sep 30, 2025 | 11.90 Mn |
| Jun 30, 2025 | 16.06 Mn |
| Mar 31, 2025 | 20.27 Mn |
| Dec 31, 2024 | 17.83 Mn |
| Sep 30, 2024 | 16.04 Mn |
| Jun 30, 2024 | 21.17 Mn |
| Mar 31, 2024 | 25.03 Mn |
| Dec 31, 2023 | 29.54 Mn |
| Sep 30, 2023 | 33.61 Mn |
| Jun 30, 2023 | 37.04 Mn |
| Mar 31, 2023 | 42.33 Mn |
| Dec 31, 2022 | 49.06 Mn |
| Sep 30, 2022 | 55.33 Mn |
| Jun 30, 2022 | 60.48 Mn |
| Mar 31, 2022 | 66.21 Mn |
| Dec 31, 2021 | 47.46 Mn |
| Sep 30, 2021 | 27.55 Mn |